126 related articles for article (PubMed ID: 160628)
1. Anticoagulant peptides obtained from human fibrinogen degradation products by plasmin.
Takagi K; Suzuki S; Kawai T
Thromb Res; 1979; 16(5-6):737-46. PubMed ID: 160628
[No Abstract] [Full Text] [Related]
2. Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin.
Belew M; Gerdin B; Porath J; Saldeen T
Thromb Res; 1978 Dec; 13(6):983-94. PubMed ID: 155325
[No Abstract] [Full Text] [Related]
3. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
Walsh PN; Griffin JH
Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
[No Abstract] [Full Text] [Related]
4. Platelets and initiation of intrinsic clotting.
Schiffman S; Rapaport SI; Chong MM
Br J Haematol; 1973 May; 24(5):633-42. PubMed ID: 4712832
[No Abstract] [Full Text] [Related]
5. Degradation of human fibrinogen by plasmin: a kinetic study.
Regañon E; Aznar J; Vila V
Thromb Res; 1977 Mar; 10(3):411-9. PubMed ID: 140473
[No Abstract] [Full Text] [Related]
6. [Action of proteolytic enzymes on fibrinogen].
Jamet M; Levy G
Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
[TBL] [Abstract][Full Text] [Related]
7. Inherited bleeding disorders and dental treatment.
Muzyka BC
Pract Proced Aesthet Dent; 2005 Aug; 17(7):489. PubMed ID: 18655338
[No Abstract] [Full Text] [Related]
8. Peri-operative management of patients with coagulation disorders.
Martlew VJ
Br J Anaesth; 2000 Sep; 85(3):446-55. PubMed ID: 11103188
[No Abstract] [Full Text] [Related]
9. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
Summaria L; Boreisha IG; Arzadon L; Robbins KC
Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
[No Abstract] [Full Text] [Related]
10. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
Gormsen J; Feddersen C
Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
[No Abstract] [Full Text] [Related]
11. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
Chan JY; Movat HZ; Burrowes CE
Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
[No Abstract] [Full Text] [Related]
12. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
Vinazzer H
Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
[No Abstract] [Full Text] [Related]
13. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
Ewald GA; Eisenberg PR
Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
Ogston D; Douglas AS
Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
[No Abstract] [Full Text] [Related]
15. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
Bańkowski E; Worowski K
Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
[No Abstract] [Full Text] [Related]
16. Enhanced anticlotting activity of fragments D formed during plasmin hydrolysis of fibrinogen in the presence of calcium chloride.
Belitser VA; Varetska TV; Tolstykh VM; Tsaryuk LA; Pozdnyakova TM
Thromb Res; 1975 Nov; 7(5):797-806. PubMed ID: 128845
[No Abstract] [Full Text] [Related]
17. Studies on the degradation of human fibrinogen by plasmin and trypsin.
Beck EA; Jackson DP
Thromb Diath Haemorrh; 1966 Dec; 16(3):526-40. PubMed ID: 4231537
[No Abstract] [Full Text] [Related]
18. The release of B beta 1-42 from fibrinogen and fibrin by plasmin.
Hurlet-Jensen A; Koehn JA; Nossel HL
Thromb Res; 1983 Mar; 29(6):609-17. PubMed ID: 6222508
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
[TBL] [Abstract][Full Text] [Related]
20. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
Alkjaersig N; Davies A; Fletcher A
Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
